Parexel

Improving the lives of patients every day #withheart. #biotech #healthcare #lifesciences #innovation

[Parexel @Parexel]

Today Parexel announced the launch of the Parexel Biotech Incubator, a new initiative that connects early-stage therapeutics companies with the clinical and regulatory expertise they need to advance their programs. https://t.co/qDpVf9YArh

[Parexel @Parexel]

On World Sickle Cell Day, we honor the strength and resilience of individuals and families living with sickle cell disease. We stand with you and will continue moving the science forward toward the treatments you deserve.​
Learn about our CAGT expertise: https://t.co/HpYRtfJ9ah

[Parexel @Parexel]

The biotech funding landscape has changed. Investors once backed promising ideas. Today, they fund clinical validation.

At #FierceBiotechWeek, Sheela Hedge and Rajiv Gangurde broke down what's changed: https://t.co/8jX56uAcKh

[Parexel @Parexel]

Voting is OPEN for the 2026 @SCRS #EagleAward! This prestigious honor recognizes one CRO and one sponsor demonstrating exceptional leadership, integrity & commitment to site partnerships.

Voted on entirely by you—our clinical research site partners: https://t.co/5qwSWE2K35

[Parexel @Parexel]

We're thrilled to showcase our expertise across eight thought leadership sessions at @DrugInfoAssn's 2026 Global Annual Meeting June 14-18 in Philadelphia!

Visit us at Booth #1503 to connect with our experts.

Read more in the press release: https://t.co/qqPdOCSiOu

[Parexel @Parexel]

In this @ACROhealth Blog, Andreas Lysandropoulos explores why Alzheimer's disease has become a proving ground for a very different CRO model — one built on orchestrating complexity across every segment: sponsors, sites, regulators, payers and patients.

👉 https://t.co/EADhiDwT8P

[Parexel @Parexel]

Parexel announced seven research posters to be presented during the @EHA_Hematology 2026 Congress in Stockholm and the launch of a hematology playbook grounded in expertise from 250 hematology programs across nearly 70 countries over the past five years: https://t.co/UjdPwMFiXs

[Parexel @Parexel]

Why do some cell and gene therapy programs succeed while others stall?​ In Drug Discovery & Development, Chris Learn explores four critical factors that can define clinical outcomes:👉 https://t.co/6w5nknUNJ0

[Parexel @Parexel]

This June, Parexel is proud to celebrate #PrideMonth2026 —a time to honor the resilience, courage and contributions of the LGBTQ+ community while reaffirming our commitment to creating a workplace where everyone feels valued and respected.

Happy Pride!🏳️‍🌈

#ParexelWithPride

[Parexel @Parexel]

Today, Parexel announced two virtual research posters accepted for presentation at the @ASCO Annual Meeting.​ As part of #ASCO2026, Parexel also launched From Insights to Life, a new patient-focused creative campaign. https://t.co/jGftmERJ4G

[Parexel @Parexel]

Congratulations to our Parexel colleagues who medaled in the 2026 @PharmaTimes International Clinical Researcher of the Year competition in London!👏Let's celebrate all of our winners and finalists who represented Parexel throughout this competition! #PTINTCR #PharmaTimes

[Parexel @Parexel]

Today, on #InternationalClinicalTrialsDay, we honor our colleagues, partners and customers whose work drives progress in global health and our patients who inspire us to accelerate the delivery of life-saving treatments.
Watch our CEO Peyton Howell share why this day matters. 💙

[Parexel @Parexel]

Read the full announcement: https://t.co/H1FAH22vEC

[Parexel @Parexel]

🚀 We're excited to introduce ParexelAI™, an innovative, proprietary suite of human-led AI services and capabilities that power Parexel operations and deliver greater speed, quality and efficiency to customers and, ultimately, patients.

[Parexel @Parexel]

ParexelAI combines our proprietary tools, internal innovation, strategic partnerships and expertise of our 22,000+ global team members — all while prioritizing human judgment, scientific and regulatory expertise, and patient safety.

Learn more: https://t.co/9AplxobOK6

[Parexel @Parexel]

The FDA's plausible mechanism framework is here and it's a significant shift for individualized therapy development. Dr. Mwango Kashoki breaks down what sponsors need to know in a new video series with @Clin_Trials. https://t.co/8iBtepXCqb

[Parexel @Parexel]

Parexel recently earned a 2025 Cornerstone Galaxy Award for "Excellence in AI-Driven Talent Strategy" from @CornerstoneInc! We created and use an AI digital worker that automates how training updates are received and resolved so colleagues can focus on more value-driving work.

[Parexel @Parexel]

We’re proud to share our new sustainability & impact report! Inside, discover our key achievements and steadfast commitment across our patients, environment, people and governance.

Explore our path forward: https://t.co/DrPnGuua62

[Parexel @Parexel]

⏩Clinical research in APAC is changing rapidly but what is making this change possible and can we predict the future of this landscape?

Vera Zheng, SVP, APAC Strategy and Head of Greater China, gives her insights below:

Read more in @pharmaboardroom: https://t.co/7Xz4RXvfGe

[Parexel @Parexel]

In a new article from @biospace, Parexel's Charlotte Moser M.D. explores why patient centricity shouldn't just be an industry buzzword. It's how we accelerate innovation and get life-changing therapies to market faster. https://t.co/pogHxMc7PO